Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase A Robicsek, J Strahilevitz, GA Jacoby, M Macielag, D Abbanat, ... Nature medicine 12 (1), 83-88, 2006 | 1492 | 2006 |
The worldwide emergence of plasmid-mediated quinolone resistance A Robicsek, GA Jacoby, DC Hooper The Lancet infectious diseases 6 (10), 629-640, 2006 | 1312 | 2006 |
Plasmid-mediated quinolone resistance: a multifaceted threat J Strahilevitz, GA Jacoby, DC Hooper, A Robicsek Clinical microbiology reviews 22 (4), 664-689, 2009 | 1202 | 2009 |
Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme CH Park, A Robicsek, GA Jacoby, D Sahm, DC Hooper Antimicrobial agents and chemotherapy 50 (11), 3953-3955, 2006 | 1017 | 2006 |
qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States A Robicsek, J Strahilevitz, DF Sahm, GA Jacoby, DC Hooper Antimicrobial agents and chemotherapy 50 (8), 2872-2874, 2006 | 802 | 2006 |
qnrB, Another Plasmid-Mediated Gene for Quinolone Resistance GA Jacoby, KE Walsh, DM Mills, VJ Walker, H Oh, A Robicsek, ... Antimicrobial agents and chemotherapy 50 (4), 1178-1182, 2006 | 665 | 2006 |
Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals A Robicsek, JL Beaumont, SM Paule, DM Hacek, RB Thomson Jr, ... Annals of internal medicine 148 (6), 409-418, 2008 | 551 | 2008 |
Myocarditis and pericarditis after vaccination for COVID-19 GA Diaz, GT Parsons, SK Gering, AR Meier, IV Hutchinson, A Robicsek Jama 326 (12), 1210-1212, 2021 | 454 | 2021 |
Plasmid-Mediated Quinolone Resistance in Non-Typhi Serotypes of Salmonella enterica K Gay, A Robicsek, J Strahilevitz, CH Park, G Jacoby, TJ Barrett, ... Clinical Infectious Diseases 43 (3), 297-304, 2006 | 363 | 2006 |
Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli JR Johnson, V Tchesnokova, B Johnston, C Clabots, PL Roberts, M Billig, ... The Journal of infectious diseases 207 (6), 919-928, 2013 | 325 | 2013 |
Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea LR Peterson, RU Manson, SM Paule, DM Hacek, A Robicsek, ... Clinical Infectious Diseases 45 (9), 1152-1160, 2007 | 284 | 2007 |
Multicenter development and validation of a risk stratification tool for ward patients MM Churpek, TC Yuen, C Winslow, AA Robicsek, DO Meltzer, ... American journal of respiratory and critical care medicine 190 (6), 649-655, 2014 | 279 | 2014 |
A whole-slide foundation model for digital pathology from real-world data H Xu, N Usuyama, J Bagga, S Zhang, R Rao, T Naumann, C Wong, ... Nature 630 (8015), 181-188, 2024 | 196 | 2024 |
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately S Schneeweiss, A Robicsek, R Scranton, D Zuckerman, DH Solomon Journal of clinical epidemiology 60 (4), 397-409, 2007 | 188 | 2007 |
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967–2009 JR Johnson, MH Nicolas-Chanoine, C DebRoy, M Castanheira, ... Emerging infectious diseases 18 (4), 598, 2012 | 184* | 2012 |
Objective surveillance definitions for ventilator-associated pneumonia M Klompas, S Magill, A Robicsek, JM Strymish, K Kleinman, RS Evans, ... Critical care medicine 40 (12), 3154-3161, 2012 | 169 | 2012 |
Diffusion-weighted imaging of fungal cerebral infection P Gaviani, RB Schwartz, ET Hedley-Whyte, KL Ligon, A Robicsek, ... American journal of Neuroradiology 26 (5), 1115-1121, 2005 | 159 | 2005 |
Performance of the BD GeneOhm Methicillin-Resistant Staphylococcus aureus Test before and during High-Volume Clinical Use SM Paule, DM Hacek, B Kufner, K Truchon, RB Thomson Jr, KL Kaul, ... Journal of clinical microbiology 45 (9), 2993-2998, 2007 | 155 | 2007 |
Does My Patient Have Clostridium difficile Infection? LR Peterson, A Robicsek Annals of internal medicine 151 (3), 176-179, 2009 | 151 | 2009 |
Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and-negative E. coli clinical … R Banerjee, A Robicsek, MA Kuskowski, S Porter, BD Johnston, ... Antimicrobial agents and chemotherapy 57 (12), 6385-6388, 2013 | 150 | 2013 |